Meet the Press NOW — April 12
Meet the Press
00:00
The Biden Administration's Response to Resubmitting the Drug for Current FDA Approval
The Biden administration could try to resubmit the drug for current FDA approval. "I think this is part of why you see big pharma coming out in force against this decision," she says. The judge's order would prevent Danco from doing that, but it'd take a really long time.
Play episode from 21:25
Transcript
